Concepedia

Derek Marshall

DM

Statistics

Publications

14

Citations

2.9K

H-Index

14

Active since

1996

Affiliations

Gilead Sciences (United States)(Current)

Boston University

Curis (United States)

Technion – Israel Institute of Technology

Derek Marshall is an author at Gilead Sciences (United States) specializing in medicine, life sciences, and pharmacology.

Publications per year

1996–2018

14

Publications

14

A paracrine requirement for hedgehog signalling in cancer

Robert L. Yauch, Stephen E. Gould, Suzie J. Scales et al. · Nature · 2008 · 955 citations

Medicine, Cancer Biology, Oncology +14

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall et al. · Nature Medicine · 2010 · 855 citations

Life Sciences, Biochemistry, Cell Biology +13

GDC-0449—A potent inhibitor of the hedgehog pathway

Kirk Robarge, Shirley A. Brunton, Georgette M. Castanedo et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 387 citations · Full text

Pharmacy, Life Sciences, Medicinal Chemistry +10

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

Derek Marshall, Susan K. Lyman, Scott McCauley et al. · PLoS ONE · 2015 · 195 citations · Full text

Medicine, Oncology, Pharmacology +17

Enzymatic digestibility and pretreatment degradation products of AFEX‐treated hardwoods (<i>Populus nigra</i>)

Venkatesh Balan, Leonardo da Costa Sousa, Shishir P. S. Chundawat et al. · Biotechnology Progress · 2009 · 144 citations

Life Sciences, Biochemistry, Biotechnology +17

1–5 of 14